Atlas Trials

Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders

Clinical trial NCT04695769 · COMPLETED

Trial details

NCT number
NCT04695769
Sponsor
Helwan University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2020-11-21
Primary completion
2021-10-21
Enrollment
281

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.